Rising Investment In Research And Development Driving The Growth Of The Market Due To Enhanced Gene Function Analysis And Innovation Emerges as a Core Driver of the Functional Genomics Market in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Functional Genomics Market Through 2025?
In the last few years, there has been a substantial increase in the size of the functional genomics market. It is expected that it will expand from $12.96 billion in 2024 to $14.84 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.5%. The surge during the historic period is accredited to the heightened concentration on studies of gene expression, the growing implementation of functional assays in the discovery of drugs, the rise in biotech firms, advancements in high-throughput screening techniques, and a soaring incorporation of bioinformatics in genomics research.

What's the Projected Size of the Global Functional Genomics Market by 2029?
In the forthcoming years, the functional genomics market is anticipated to witness expedited expansion, escalating to $25.19 billion in 2029 with an impressive 14.2% compound annual growth rate (CAGR). The anticipated growth within the prediction period is predominantly due to the escalating investments in precision medicine, a surge in the adoption of multi-omics tactics, a rising need for cutting-edge genetic testing, expanding application of functional genomics in oncology, and a growth in investment in R&D . Key trends for the forecast period encompass progress in single-cell sequencing technologies, the creation of cloud-based genomic data platforms, innovation in high-throughput functional screening methods, progression in merging genomics with proteomics, and the evolution of personalized therapeutic methods exploiting functional genomics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/functional-genomics-global-market-report

Top Growth Drivers in the Functional Genomics Industry: What's Accelerating the Market?
The functional genomics market is set to be fueled by the rising investments in research and development. R&D activities, which are structured initiatives to innovate, enhance, and create products, processes, or knowledge, are escalating, given that companies are striving for innovation to maintain competitiveness. Such companies are therefore directing more resources towards creating new products, enhancing technologies, and exploiting opportunities in emerging markets. By facilitating the identification and analysis of gene functions, R&D investments positively impact functional genomics, thus deepening our comprehension of complex biological processes and aiding in the development of accurate therapeutic strategies. For example, the Department of Health and Social Care, a government department in the UK, in December 2022, revealed that the government would invest £105 million to expedite the diagnosis of rare genetic conditions in newborns, with the objective of providing crucial, possibly life-saving treatments for a substantial number of infants. This financial backing will boost research aimed at promoting genomic healthcare by examining patients' DNA. Hence, the growing investments in R&D activities are bolstering the expansion of the functional genomics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28228&type=smp

What Trends Will Shape the Functional Genomics Market Through 2029 and Beyond?
Leading entities in the functional genomics market are focusing on devising superior methods, such as high-throughput sequencing, for imparting incredibly precise and comprehensive understanding of complicated genomes. High-throughput sequencing is an approach that enables fast and concurrent sequencing of extensive volumes of DNA or RNA to scrutinize genetic information on a wide scale. For example, Roche, a pharmaceutical company headquartered in Switzerland, introduced sequencing by expansion (SBX) technology in February 2025, thus creating a fresh genre of next-generation sequencing. SBX chemistry, in combination with a sophisticated sensor module, facilitates incredibly fast, high-throughput sequencing that is adaptable and scalable for assorted applications. This groundbreaking technique converts the DNA or RNA sequence into a measurable surrogate polymer identified as an Xpandomer via an exact biochemical transformation. Xpandomers, that are fifty times bigger than the parent nucleic acid, turn sequence information into robust, low-noise signals for unambiguous and trustworthy detection. This process, by employing a CMOS-based sensor with parallel processing, delivers incredibly accurate single-molecule nanopore sequencing with extraordinary speed and adaptability.

What Are the Main Segments in the Functional Genomics Market?
The functional genomics market covered in this report is segmented as

1) By Product: Kits And Assays, Instruments
2) By Technology: Next-Generation Sequencing (NGS), Microarray Analysis, CRISPR And Gene Editing Technologies, RNA Sequencing (RNA-Seq)
3) By End-User: Academic And Research Institutes, Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations (CROs), Clinical Laboratories, Agricultural Biotechnology Companies

Subsegments:
1) By Kits And Assays: PCR Kits, Microarray Kits, NGS Kits, Reagents, Enzymes
2) By Instruments: Sequencers, Microarray Scanners, PCR Instruments, Automation Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28228&type=smp

Which Top Companies are Driving Growth in the Functional Genomics Market?
Major companies operating in the functional genomics market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Perkin Elmer Inc., Revvity Inc., Exact Sciences Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Integrated DNA Technologies Inc., Promega Corporation, Pacific Biosciences of California Inc., Genomics Ltd., MEDiC LLC, Enhanc3D Genomics Ltd., Samplix, Arima Genomics Inc., Phase Genomics Inc.

Which Regions Will Dominate the Functional Genomics Market Through 2029?
North America was the largest region in the functional genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in functional genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28228

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.